Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.43 |
| ▸ | CA1 | P00915 | 2/20 | 0.40 |
| ▸ | MMP1 | P03956 | 2/20 | 0.40 |
| ▸ | MMP2 | P08253 | 2/20 | 0.40 |
| ▸ | MMP9 | P14780 | 2/20 | 0.40 |
| ▸ | MMP8 | P22894 | 2/20 | 0.40 |
| ▸ | MMP13 | P45452 | 2/20 | 0.40 |
| ▸ | F2 | P00734 | 4/20 | 0.36 |
| ▸ | PRSS1 | P07477 | 4/20 | 0.36 |
| ▸ | PRSS2 | P07478 | 4/20 | 0.36 |
| ▸ | PRSS3 | P35030 | 4/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22588954 | 1.00 | CA2 (0.43) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL3959116 | 1.00 | CA2 (0.43) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL22588994 | 1.00 | CA2 (0.43) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL11070771 | 1.00 | CA2 (0.43) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL28149277 | 0.98 | CA2 (0.41) | CA2CA1MMP1MMP2MMP9 | |
| Ammonia Solution, Strong SCHEMBL10882424 | 0.98 | CA2 (0.41) | CA2CA1MMP1MMP2MMP9 | |
| Ammonia Solution, Strong SCHEMBL28633760 | 0.98 | CA2 (0.41) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL6128368 | 0.98 | CA2 (0.39) | CA2CA1MMP1MMP2MMP9 | |
| Dimethylamine SCHEMBL28632094 | 0.92 | CA2 (0.39) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL4121582 | 0.90 | CA2 (0.36) | CA2CA1MMP1MMP2MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250020953-A1 | POLARIZER AND LIQUID CRYSTAL DISPLAY DEVICE | TCL CHINA STAR OPTOELECTRONICS TECHNOLOGY CO., LTD. (CN) | 2025-01-16 | — | — | US | disclosed |
| US-11251433-B2 | Nitrogen-sulfur-carbon nanocomposites and their application as cathode materials in lithium-sulfur batteries | UT-BATTELLE, LLC (US) | 2022-02-15 | — | — | US | disclosed |
| US-11186893-B2 | Rare earth amide compositions | UT-BATTELLE, LLC (US) | 2021-11-30 | — | — | US | disclosed |
| US-20200370144-A1 | METHODS FOR LIQUID EXTRACTION OF RARE EARTH METALS USING IONIC LIQUIDS | UT-BATTELLE, LLC (US) | 2020-11-26 | — | — | US | disclosed |
| US-10689727-B2 | Methods for liquid extraction of rare earth metals using ionic liquids | UT-BATTELLE, LLC (US) | 2020-06-23 | — | — | US | disclosed |
| US-20180309130-A1 | NITROGEN-SULFUR-CARBON NANOCOMPOSITES AND THEIR APPLICATION AS CATHODE MATERIALS IN LITHIUM-SULFUR BATTERIES | UT-BATTELLE, LLC (US) | 2018-10-25 | — | — | US | disclosed |
| US-10044039-B2 | Nitrogen-sulfur-carbon nanocomposites and their application as cathode materials in lithium-sulfur batteries | UT-BATELLE, LLC (US) | 2018-08-07 | — | — | US | disclosed |
| US-20170306439-A1 | METHODS FOR LIQUID EXTRACTION OF RARE EARTH METALS USING IONIC LIQUIDS | UT-BATTELLE, LLC | 2017-10-26 | — | — | US | disclosed |
| US-9722245-B2 | Sulfur-carbon nanocomposites and their application as cathode materials in lithium-sulfur batteries | UT-BATTELLE, LLC (US) | 2017-08-01 | — | — | US | disclosed |
| US-20160365581-A1 | NITROGEN-SULFUR-CARBON NANOCOMPOSITES AND THEIR APPLICATION AS CATHODE MATERIALS IN LITHIUM-SULFUR BATTERIES | UT-BATELLE, LLC (US) | 2016-12-15 | — | — | US | disclosed |
| WO-2011028804-A2 | SULFUR-CARBON NANOCOMPOSITES AND THEIR APPLICATION AS CATHODE MATERIALS IN LITHIUM-SULFUR BATTERIES | UT-BATTELLE, LLC (US) | 2011-03-10 | — | — | WO | disclosed |
| US-20110052998-A1 | SULFUR-CARBON NANOCOMPOSITES AND THEIR APPLICATION AS CATHODE MATERIALS IN LITHIUM-SULFUR BATTERIES | UT-BATTELLE, LLC (US) | 2011-03-03 | — | — | US | disclosed |
| US-20110042653-A1 | Near-Infrared Absorbing Film Compositions | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2011-02-24 | — | — | US | disclosed |
| WO-2011022221-A2 | NEAR-INFRARED ABSORBING FILM COMPOSITIONS | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2011-02-24 | — | — | WO | disclosed |
| US-20110042771-A1 | Near-Infrared Absorbing Film Compositions | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2011-02-24 | — | — | US | disclosed |
| US-20100311615-A1 | METHOD FOR SYNTHESIS OF TITANIUM DIOXIDE NANOTUBES USING IONIC LIQUIDS | UT-BATTELLE, LLC (US) | 2010-12-09 | — | — | US | disclosed |
| US-20060093554-A1 | Galenical formulations | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2006-05-04 | — | — | US | disclosed |
| US-20050074409-A1 | Use of perfluoroalkyl-containing metal complexes as contrast media in MR-imaging for visualization of plaque, tumors and necroses | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2005-04-07 | — | — | US | disclosed |
| US-6818203-B2 | COMPLEXES HAVE CRITICAL MICELLE FORMATION CONCENTRATION, HYDRODYNAMIC MICELLE DIAMETER, AND PROTON RELAXIVITY IN PLASMA CONTRAST MEDIA IN MR IMAGING | SCHERING AKTIENGESELLSCHAFT (DE) | 2004-11-16 | — | — | US | disclosed |
| US-20030072713-A1 | Use of perfluoroalkyl-containing metal complexes as contrast media in MR-imaging for visualization of plaque, tumors and necroses | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2003-04-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030072713-A1 | Use of perfluoroalkyl-containing metal complexes as contrast media in MR-imaging for visualization of plaque, tumors and necroses | FABP3, PRF1, PTDSS1 | CA2 494/4885CA1 205/4885MMP1 252/4885 |
| US-20050074409-A1 | Use of perfluoroalkyl-containing metal complexes as contrast media in MR-imaging for visualization of plaque, tumors and necroses | FABP3, PRF1, MALT1 | CA2 723/4885CA1 247/4885MMP1 134/4885 |
| US-20060093554-A1 | Galenical formulations | GALC, GALR2, GALR1 | CA2 2890/4885CA1 2871/4885MMP1 4375/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.